zPREDICTA
zPREDICTA is developing an in vitro human airway model to screen new and repurposed agents against SARS-CoV-2. Our reconstructed lung (r-Lung-SARS-CoV-2) platform is designed to assist pharmaceutical, biotech, and academic researchers in identifying antivirals for COVID-19.
Rankings by
National Ranking515th
in United States Regional Ranking584th
in North America and Caribbean Global Ranking1419th
worldwide